Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-703-2 | CAS number: 1644-11-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 2015
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- 1,1,1,2,3,3-hexafluoro-2-(heptafluoropropoxy)-3-[(trifluorovinyl)oxy]propane
- EC Number:
- 216-703-2
- EC Name:
- 1,1,1,2,3,3-hexafluoro-2-(heptafluoropropoxy)-3-[(trifluorovinyl)oxy]propane
- Cas Number:
- 1644-11-7
- Molecular formula:
- C8F16O2
- IUPAC Name:
- 1,1,1,2,2,3,3-heptafluoro-3-({1,1,1,2,3,3-hexafluoro-3-[(1,2,2-trifluoroethenyl)oxy]propan-2-yl}oxy)propane
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 3M Company, Lot 116B2018
- Expiration date of the lot/batch:
- Purity test date: 15 November, 2016
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: No data
- Stability under test conditions: No data
- Solubility and stability of the test substance in the solvent/vehicle: Material was soluble in isopropyl alcohol
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: No data
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test material was prepared in isopropyl alcohol.
- Preliminary purification step (if any):
- Final dilution of a dissolved solid, stock liquid or gel: 100 mM.
In chemico test system
- Details on the study design:
- Skin sensitisation (In chemico test system) - Details on study design: The objective of the study was to determine the skin sensitization potential of the test article based on the depletion of cysteine and/or lysine peptides following 24 hours of incubation at 25 C. Relative peptide concentration was measured by high performance liquid chromotagraphy (HPLC) with gradient elution and ultraviolet detection at 220 nm. Cysteine and lysine peptide percent depletion values were calculated and used in a prediction model which allowed the assigning of the test chemical to one of four reactivity classes used to support the discrimination between sensitizers and non-sensitizers.
Results and discussion
- Positive control results:
- The percent cysteine depletion values for the positive control sample replicates ranged from 70.2 to 71.3%. The percent lysine depletion values for the positive control sample replicates ranged from 63.6 to 66.0%. The mean percent cysteine and lysine depletion values for the respective positive control samples were 70.7 ± 0.6% (N = 3; CV = 0.816%) and 64.5 ± 1.3% (N = 3; CV = 2.06%), respectively. The mean percent cysteine and lysine depletion values for the respective positive control samples were in the range allowed by the OECD guideline (1). Precipitate was not present in the cysteine positive control samples upon initial preparation (i.e. 0 hours) and following approximately 24 hours of incubation. Precipitate was not present in the lysine positive control samples upon initial preparation (i.e. 0 hours) but was present following approximately 24 hours of incubation.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Parameter:
- other: Cysteine Depletion
- Remarks:
- Cysteine Depletion
- Value:
- 1.88
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Cysteine Depletion Percentage
- Remarks:
- Thy Cysteine Depletion value was 1.88% compared to the negative control.
- Key result
- Parameter:
- other: Lysine Depletion
- Remarks:
- Lysine Depletion
- Value:
- 0
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: Lysine Depletion Percentage
- Remarks:
- The lysine depletion percentage was 0.0% compared to controls.
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes
- Acceptance criteria met for positive control: Yes
- Acceptance criteria met for variability between replicate measurements: The HPLC/UV system suitability assay is considered to be valid if the following conditions are met: a.) the calibration curve should have an r2 >0.99; b.) the mean peptide concentration of reference controls (Set A) should be 0.50 ± 0.05 mM and the coefficient of variation (CV) of peptide peak areas for the nine reference controls B and C in ACN should be < 15.0%; c.) the mean percent depletion values of the three positive control replicates should be between 60.8% and 100% with a standard deviation (SD) as of < 14.9% for the cysteine peptide and between 40.2% and 69.0% with an SD of < 11.6% for the lysine peptide. The test chemical data should be considered to be valid if the following criteria are met: a.) the mean peptide concentration of the reference controls (Set C) for the appropriate solvent used should be 0.50 ± 0.05 mM; b.) the SD for the percent depletion values of the three test substance replicates should be < 14.9% for the cysteine peptide and < 11.6% for the lysine peptide. Negative depletion is considered as “0%” when calculating the mean.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the results of the study, the test article is considered to have no or minimal cysteine and lysine reactivity and a negative DPRA prediction.
- Executive summary:
The skin sensitization potential of the test article was evaluated in the Direct Peptide Reactivity Assay (DPRA). The assay was conducted according to OECD guideline 442C. The study was performed in compliance with OECD GLP (1997). The test article was prepared at concentration of 100 mM in isopropyl alcohol and 50 uL of the test material solution was incubated for 24 hours at 25 degrees C with 750 uL of the stock cysteine peptide solution. Similarly, 250 uL of the test article solution was incubated for 24 hours at 25 degrees C with 750 uL of lysine peptide stock solution. Appropriate positive (100 mM cinnamic aldehyde) and negative (100 mM Ammonium Acetate Buffer) controls were run in parallel. Following incubation, relative peptide concentrations were measured by high performance liquid chromotagraphy (HPLC) with gradient elution and ultraviolet detection at 220 nm. Cysteine and lysine peptide percent depletion values were calculated compared to negative control values and used in a prediction model which allowed the assigning of the test chemical to one of four reactivity classes used to support the discrimination between sensitizers and non-sensitizers. The mean percent cysteine depletion for the test substance assay samples was 1.88 ± 0.57% (N = 3; CV = 30.3%). The mean percent lysine depletion for the test substance assay samples was 0.00 ± 0.00% (N = 3). Precipitate was not present in the cysteine test substance assay samples upon initial preparation of both test substance solutions (i.e. 0 hours) and following approximately 24 hours of incubation. Precipitate was present in the lysine test substance assay samples upon initial preparation of both test substance solutions (i.e. 0 hours) and following approximately 24 hours of incubation. Based on the results of the study, the test article is considered to have no or minimal cysteine and lysine reactivity and a negative DPRA prediction.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.